Product Description: Raxofelast (IRFI-016) is an antioxidant agent in various models of ischemia-reperfusion injury. Raxofelast has antiproliferative activity in H2O2-stimulated rat aortic smooth muscle cells. Raxofelast attenuates the activation of mitogen-activating protein kinase (MAPK), ERK kinase 1, 2 (MEK1,2) and protein kinase C (PKC) without affecting Ras expression[1].
Applications: Neuroscience-Neuromodulation
Formula: C15H18O5
References: [1]Kyung-Hye Lee, et al. Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells. Eur J Pharmacol. 2004, 484, 2-3.
CAS Number: 128232-14-4
Molecular Weight: 278.30
Research Area: Cardiovascular Disease
Solubility: 10 mM in DMSO
Target: ERK;p38 MAPK;PKC